よむ、つかう、まなぶ。
参考資料4 有効性評価に基づく子宮頸がん検診ガイドライン更新版2020年３月31日 (63 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_25869.html |
| 出典情報 | がん検診のあり方に関する検討会（第35回 5／25）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
40) Fernandez ME, McCurdy SA, Arvey SR, Tyson SK, Morales-Campos D, Flores B,
Useche B, Mitchell-Bennett L, Sanderson M. HPV knowledge, attitudes, and cultural
beliefs among Hispanic men and women living on the Texas-Mexico border. Ethn Health.
2009; 14(6): 607-624.
41) Vanslyke JG, Baum J, Plaza V, Otero M, Wheeler C, Helitzer D. HPV and cervical
cancer testing and prevention: knowledge, beliefs, and attitudes among Hispanic women.
Qual Health Res. 2008; 18(5): 584-96.
42) Daley EM, Perrin KM, McDermott RJ, Vamos CA, Rayko HL, Packing-Ebuen JL,
Webb C, McFarlane M. The psychosocial burden of HPV: a mixed-method study of
knowledge, attitudes and behaviors among HPV+ women. J Health Psychol. 2010; 15(2):
279-290.
43) Sasieni P, Castanon A, Cuzick J, Snow J. Effectiveness of cervical screening with age:
population based case-control study of prospectively recorded data. BMJ. 2009; 339:
b2968.
44) Vicus D, Sutradhar R, Lu Y, Elit L, Kupets R, Paszat L; Investigators of the Ontario
Cancer Screening Research Network. The association between cervical cancer screening
and mortality from cervical cancer: a population based case-control study. Gynecol Oncol.
2014; 133(2): 167-171.
45) Yang B, Morrell S, Zuo Y, Roder D, Tracey E, Jelfs P. A case-control study of the
protective benefit of cervical screening against invasive cervical cancer in NSW women.
Cancer Causes Control. 2008; 19(6): 569-576.
46) Andrae B, Kemetli L, Sparén P, Silfverdal L, Strander B, Ryd W, Dillner J, Törnberg
S. Screening-preventable cervical cancer risks: evidence from a nationwide audit in
Sweden. J Natl Cancer Inst. 2008; 100(9): 622-629.
47) Lönnberg S, Anttila A, Luostarinen T, Nieminen P. Age-specific effectiveness of the
Finnish cervical cancer screening programme. Cancer Epidemiol Biomarkers Prev. 2012;
21(8): 1354-1361.
48) Castañón A, Landy R, Cuzick J, Sasieni P. Cervical screening at age 50―64 years
and the risk of cervical cancer at age 65 years and older: population-based case control
study. PLoS Med. 2014; 11(1): e1001585.
49) Lönnberg S, Nieminen P, Luostarinen T, Anttila A. Mortality audit of the Finnish
cervical cancer screening program. Int J Cancer. 2013; 132(9): 2134-2140.
50) Rosenblatt KA, Osterbur EF, Douglas JA. Case-control study of cervical cancer and
gynecologic screening: A SEER-Medicare analysis. Gynecol Oncol. 2016; 142(3): 395-400.
Useche B, Mitchell-Bennett L, Sanderson M. HPV knowledge, attitudes, and cultural
beliefs among Hispanic men and women living on the Texas-Mexico border. Ethn Health.
2009; 14(6): 607-624.
41) Vanslyke JG, Baum J, Plaza V, Otero M, Wheeler C, Helitzer D. HPV and cervical
cancer testing and prevention: knowledge, beliefs, and attitudes among Hispanic women.
Qual Health Res. 2008; 18(5): 584-96.
42) Daley EM, Perrin KM, McDermott RJ, Vamos CA, Rayko HL, Packing-Ebuen JL,
Webb C, McFarlane M. The psychosocial burden of HPV: a mixed-method study of
knowledge, attitudes and behaviors among HPV+ women. J Health Psychol. 2010; 15(2):
279-290.
43) Sasieni P, Castanon A, Cuzick J, Snow J. Effectiveness of cervical screening with age:
population based case-control study of prospectively recorded data. BMJ. 2009; 339:
b2968.
44) Vicus D, Sutradhar R, Lu Y, Elit L, Kupets R, Paszat L; Investigators of the Ontario
Cancer Screening Research Network. The association between cervical cancer screening
and mortality from cervical cancer: a population based case-control study. Gynecol Oncol.
2014; 133(2): 167-171.
45) Yang B, Morrell S, Zuo Y, Roder D, Tracey E, Jelfs P. A case-control study of the
protective benefit of cervical screening against invasive cervical cancer in NSW women.
Cancer Causes Control. 2008; 19(6): 569-576.
46) Andrae B, Kemetli L, Sparén P, Silfverdal L, Strander B, Ryd W, Dillner J, Törnberg
S. Screening-preventable cervical cancer risks: evidence from a nationwide audit in
Sweden. J Natl Cancer Inst. 2008; 100(9): 622-629.
47) Lönnberg S, Anttila A, Luostarinen T, Nieminen P. Age-specific effectiveness of the
Finnish cervical cancer screening programme. Cancer Epidemiol Biomarkers Prev. 2012;
21(8): 1354-1361.
48) Castañón A, Landy R, Cuzick J, Sasieni P. Cervical screening at age 50―64 years
and the risk of cervical cancer at age 65 years and older: population-based case control
study. PLoS Med. 2014; 11(1): e1001585.
49) Lönnberg S, Nieminen P, Luostarinen T, Anttila A. Mortality audit of the Finnish
cervical cancer screening program. Int J Cancer. 2013; 132(9): 2134-2140.
50) Rosenblatt KA, Osterbur EF, Douglas JA. Case-control study of cervical cancer and
gynecologic screening: A SEER-Medicare analysis. Gynecol Oncol. 2016; 142(3): 395-400.